CD38
protein-codingCD38 molecule, the group of CD molecules
Gene summary
The protein encoded by this gene is a non-lineage-restricted, type II transmembrane glycoprotein that synthesizes and hydrolyzes cyclic adenosine 5'-diphosphate-ribose, an intracellular calcium ion mobilizing messenger. The release of soluble protein and the ability of membrane-bound protein to become internalized indicate both extracellular and intracellular functions for the protein. This protein has an N-terminal cytoplasmic tail, a single membrane-spanning domain, and a C-terminal extracellular region with four N-glycosylation sites. Crystal structure analysis demonstrates that the functional molecule is a dimer, with the central portion containing the catalytic site. It is used as a prognostic marker for patients with chronic lymphocytic leukemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~75.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CD38 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001775.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | ||||
| missense | 34 | 3 | 37 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 7 | 7 | ||||
| Total | 0 | 0 | 41 | 3 | 1 | 45 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001766.2 | 8 | MANE Select | |
| Ensembl | ENSP00000226279.2 | 8 | MANE Select | |
| Ensembl | ENSP00000427277.1 | 3 | Standard | |
| Ensembl | ENSP00000423047.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Oxytocin signaling pathway - Homo sapiens (human)
- Nicotinate and nicotinamide metabolism - Homo sapiens (human)
- Calcium signaling pathway - Homo sapiens (human)
- Salivary secretion - Homo sapiens (human)
- Pancreatic secretion - Homo sapiens (human)
Biological Process
- response to hypoxia
- signal transduction
- positive regulation of cytosolic calcium ion concentration
- female pregnancy
- negative regulation of neuron projection development
Molecular Function
- NAD+ nucleosidase activity
- transferase activity
- phosphorus-oxygen lyase activity
- identical protein binding
- NAD(P)+ nucleosidase activity
Cellular Component
- nucleus
- plasma membrane
- cell surface
- membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000226279
- Coding exons
- 8
- Length
- 74956
- Individuals with no LoFs
- 125539
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 208
- Defined
- 125748
- p
- 0.000831
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.0647 | 167 | 165 | 1.01 | 0.00000800 | 1982 |
| Missense (PolyPhen) | 49 | 51.685 | 0.94805 | 668 | ||
| Synonymous | 0.961 | 52 | 61.6 | 0.844 | 0.00000306 | 548 |
| Loss of Function | 1.19 | 11 | 16.2 | 0.680 | 6.88e-7 | 180 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0088 | 0.0083 | notable |
| Latino/Admixed American | 0.00081 | 0.00078 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00033 | 0.00033 | rare |
| South Asian | 0.000066 | 0.000065 | rare |
| Other | 0.0010 | 0.00098 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Synthesizes the second messagers cyclic ADP-ribose and nicotinate-adenine dinucleotide phosphate, the former a second messenger for glucose-induced insulin secretion. Also has cADPr hydrolase activity. Also moonlights as a receptor in cells of the immune system.;
Recessive Scores
- pRec
- 0.355
Intolerance Scores
- LoFtool
- 0.890
- RVIS EVS
- -0.6
- RVIS percentile EVS
- 17.91
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.985
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |